argenx SE
(STU:1AE)
€
553.6
6 (1.1%)
Market Cap: 33.43 Bil
Enterprise Value: 30.56 Bil
PE Ratio: 0
PB Ratio: 8.44
GF Score: 82/100 argenx SE at Bank of America Healthcare Conference Transcript
May 11, 2022 / 05:40PM GMT
Release Date Price:
€279.9
(+5.62%)
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Thank you for joining us. I'm Tazeen Ahmad. I'm one of the senior biotech analyst here at Bank of America. It is my pleasure to have our next presenting company with us, argenx.
Sitting next to me is Tim Van Hauwermeiren, who is Chief Executive Officer of the company. Tim, thank you for making the trip from Belgium.
Timothy Van Hauwermeiren
argenx SE - CEO & Executive Director
Thank you for having us, Tazeen. It's always a pleasure.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
And we're back live here in Vegas, obviously. So maybe for those who aren't as familiar with the company, can you just give us a quick 2-minute overview of the platform and some recent developments? And then we can go into some more detailed Q&A after that.
Timothy Van Hauwermeiren
argenx SE - CEO & Executive Director
Very happy
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot